Changes

== Main characteristics ==

The device consists of two separate pieces, the body temperature monitor, and the processing unit that wirelessly connects to the provided mobile app.

=== Purpose ===

The purpose of the device is to help pair with infertility by analysing the data about the women's ovulation and offering advice on when is the best time to conceive.

=== Company & People ===

DuoFertility is developed by a British company Cambridge Temperature Concepts Ltd. The company is based in Cambridge and was established in 2005. It focuses on the development of continuous physiological monitoring devices.<ref>http://www.temperatureconcepts.com/</ref><ref>https://www.crunchbase.com/organization/cambridge-temperature-concepts#/entity</ref>

== Important Dates ==

* 2005 - Cambridge Temperature Concepts founded.<ref name="businesswire" />

* January 2009 - The device obtains European Medical Devices Directive approval.<ref name="businesswire" />

== Enhancement/Therapy/Treatment ==

== Ethical & Health Issues ==

== Public & Media Impact and Presentation ==

There are numerous articles about DuoFertility to be found, as well as user reviews and discussions.

Mobihealthnews has several articles in which DuoFertility is mentioned.<ref>http://mobihealthnews.com/tag/duofertility</ref> The first one discusses the presentation of DuoFertility at the Wireless Life-Sciences Alliance in San Diego in 2011. The article stated that the device was among the surprising presentation during that event and that it "really does span the continuum of health care" thanks to its incorporation of wireless technology.<ref>http://mobihealthnews.com/11042/wireless-health-opportunity-begins-at-conception</ref> Another article informs about the device receiving the approval of the US Food and Drug Administration and that it took almost two years to receive.<ref>http://mobihealthnews.com/16028/duofertility-wireless-sensor-receives-fda-clearance</ref> Next article informs about DuoFertility receiving the FDA approval in the US. It explains what the device is and what is does in general terms and concludes with an official press release by Cambridge Temperature Concepts Ltd.<ref>http://mobihealthnews.com/17150/duofertility-commercially-launches-in-us-for-795</ref> Next article discusses wearables targeted on women and mentions DuoFertility among other products centred around female ovulation.<ref>http://mobihealthnews.com/19907/digital-health-fertility-services-ramping-up</ref> The similar approach is used in another article that compares the device to other fertility trackers.<ref>http://mobihealthnews.com/30449/five-digital-health-tools-for-tracking-fertility</ref> And the latest article devoted to DuoFertility informas about the company securing more funds in order to "to expand product sales in the US and develop the next iteration of the DuoFertility tracker, which will offer smartphone connectivity and the ability to measure more metrics".<ref>http://mobihealthnews.com/35450/duofertility-maker-raises-4m-to-improve-fertility-tracker-add-smartphone-connection</ref>

TechCrunch magazine article opens with a then CEO of the company Shamus Husheer stating that, in comparison to other similar devices, DuoFertility has a much higher success rate. The article continues with a description on the device's features with Husheer's commentary included. The article concludes with the history of the company and the story of how they entered the American market.<ref>http://techcrunch.com/2013/04/01/duofertility/</ref>